Skip to Main Content

Author Details

Darlene Veruttipong
Stanford University
2012
29
15
PMIDPaper TitleJournal TitlePublished Year
35576446Gearing Up for a Vaccine Requirement: A Mixed Methods Study of COVID-19 Vaccine Confidence Among Workers at an Academic Medical Center.J Healthc Manag2022
33421991Relationship of socio-demographics, comorbidities, symptoms and healthcare access with early COVID-19 presentation and disease severity.BMC Infect Dis2021
34546949Financial Incentives for Medical Assistants: A Mixed-Methods Exploration of Bonus Structures, Motivation, and Population Health Quality Measures.Ann Fam Med2021
31693450Negotiating Lay and Clinical Issues: Implementing a Lay Navigation Program in Cancer Care.JCO Oncol Pract2020
31647691Effectiveness of a Lay Navigation Program in an Academic Cancer Center.JCO Oncol Pract2020
27672743Outcomes of Node-positive Breast Cancer Patients Treated With Accelerated Partial Breast Irradiation Via Multicatheter Interstitial Brachytherapy: The Pooled Registry of Multicatheter Interstitial Sites (PROMIS) Experience.Am J Clin Oncol2018
29573279FDG-PET metabolic tumor parameters for the reirradiation of recurrent head and neck cancer.Laryngoscope2018
29573121Head and neck cancer reirradiation with interstitial high-dose-rate brachytherapy.Head Neck2018
29246721Functional Outcomes After De-escalated Chemoradiation Therapy for Human Papillomavirus-Positive Oropharyngeal Cancer: Secondary Analysis of a Phase 2 Trial.Int J Radiat Oncol Biol Phys2018
29044458Patient-reported quality-of-life outcomes after de-escalated chemoradiation for human papillomavirus-positive oropharyngeal carcinoma: Findings from a phase 2 trial.Cancer2018
28537990Impact of the Primary Information Source Used for Decision Making on Treatment Perceptions and Regret in Prostate Cancer.Am J Clin Oncol2018
27965117High-dose-rate brachytherapy monotherapy without androgen deprivation therapy for intermediate-risk prostate cancer.Brachytherapy2017
29904734Hazards of sparing the ipsilateral parotid gland in the node-positive neck with intensity modulated radiation therapy: Spatial analysis of regional recurrence risk.Adv Radiat Oncol2017
28351580Re-irradiation for recurrent and second primary cancers of the head and neck.Oral Oncol2017
28126301Exploring Value From the Patient's Perspective Between Modern Radiation Therapy Modalities for Localized Prostate Cancer.Int J Radiat Oncol Biol Phys2017
28597076Juxtapapillary and circumpapillary choroidal melanoma: globe-sparing treatment outcomes with iodine-125 notched plaque brachytherapy.Graefes Arch Clin Exp Ophthalmol2017
28807747Pretreatment 3T multiparametric MRI staging predicts for biochemical failure in high-risk prostate cancer treated with combination high-dose-rate brachytherapy and external beam radiotherapy.Brachytherapy2017
28552819Prostate Cancer Antigen 3 Score Does Not Predict for Adverse Pathologic Features at Radical Prostatectomy or for Progression-free Survival in Clinically Localized, Intermediate- and High-risk Prostate Cancer.Urology2017
28551359Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial.Lancet Oncol2017
27908620Location Matters: Stage I Non-Small-cell Carcinomas of the Lower Lobes Treated With Stereotactic Body Radiation Therapy Are Associated With Poor Outcomes.Clin Lung Cancer2017
26764282The significance of PTV dose coverage on cancer control outcomes in early stage non-small cell lung cancer patients treated with highly ablative stereotactic body radiation therapy.Br J Radiol2016
28740893Stereotactic body radiotherapy (SBRT) for locally advanced extrahepatic and intrahepatic cholangiocarcinoma.Adv Radiat Oncol2016
26372098Pretreatment Immune Parameters Predict for Overall Survival and Toxicity in Early-Stage Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.Clin Lung Cancer2016
26524087Utilizing time-driven activity-based costing to understand the short- and long-term costs of treating localized, low-risk prostate cancer.Cancer2016
27720202Time-driven activity-based costing of low-dose-rate and high-dose-rate brachytherapy for low-risk prostate cancer.Brachytherapy2016
28029448Long term results from a prospective database on high dose rate (HDR) interstitial brachytherapy for primary cervical carcinoma.Gynecol Oncol2016
27234604Pretreatment Anemia Portends Poor Survival and Nonlocal Disease Progression in Patients with Stage I Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy.J Thorac Oncol2016
25916980Outcomes of Breast Cancer Patients Treated with Accelerated Partial Breast Irradiation Via Multicatheter Interstitial Brachytherapy: The Pooled Registry of Multicatheter Interstitial Sites (PROMIS) Experience.Ann Surg Oncol2015
22912550Age distribution, polyps and rectal cancer in the Egyptian population-based cancer registry.World J Gastroenterol2012
  • 1 - 29 of 29

Recommended Authors

Fang-I Chu
David Geffen School of Medicine, University of California los angeles
Career Start Year 2018
Number of shared co-authors 11
Chenyang Wang
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Career Start Year 2017
Number of shared co-authors 11
Luca F Valle
University of California los angeles
Career Start Year 2016
Number of shared co-authors 9
Hilary P Bagshaw
Stanford University
Career Start Year 2014
Number of shared co-authors 7
Erqi L Pollom
Stanford University
Career Start Year 2014
Number of shared co-authors 7
Soumyajit Roy
Rush University Medical Center
Career Start Year 2013
Number of shared co-authors 4
Andrew Warner
Western University and London Regional Cancer Program
Career Start Year 2013
Number of shared co-authors 0
Rachel M Glicksman
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 3
William C Jackson
University of Michigan ann arbor
Career Start Year 2013
Number of shared co-authors 7
Nicholas G Zaorsky
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Career Start Year 2012
Number of shared co-authors 9
Nikhil T Sebastian
Emory University
Career Start Year 2011
Number of shared co-authors 0
Christine Massey
Princess Margaret Cancer Centre
Career Start Year 2010
Number of shared co-authors 0
Ting Martin Ma
University of Washington
Career Start Year 2010
Number of shared co-authors 9
Michael Xiang
University of California los angeles
Career Start Year 2007
Number of shared co-authors 11
Bradley J Stish
Mayo Clinic
Career Start Year 2007
Number of shared co-authors 6
Rahul D Tendulkar
Taussig Cancer Institute, Cleveland Clinic
Career Start Year 2006
Number of shared co-authors 6
Sunita Ghosh
Cross Cancer Institute
Career Start Year 2006
Number of shared co-authors 0
Eyad Abu-Isa
Ascension Providence Hospital
Career Start Year 2005
Number of shared co-authors 8
Nima Aghdam
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 7
Alejandro Berlin
University of Toronto, Princess Margaret Cancer Centre
Career Start Year 2004
Number of shared co-authors 6
Albert J Chang
University of California Los Angeles
Career Start Year 2003
Number of shared co-authors 10
Neha Vapiwala
Abramson Cancer Center, University of Pennsylvania
Career Start Year 2001
Number of shared co-authors 6
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 0
Chiaojung Jillian Tsai
Memorial Sloan Kettering Cancer Center
Career Start Year 2000
Number of shared co-authors 2
David A Palma
University of Western Ontario
Career Start Year 2000
Number of shared co-authors 0
Drew Moghanaki
University of California Los Angeles
Career Start Year 2000
Number of shared co-authors 5
Chandana A Reddy
Cleveland Clinic
Career Start Year 2000
Number of shared co-authors 9
Robert B Den
Thomas Jefferson University Hospital
Career Start Year 1999
Number of shared co-authors 4
Constantine A Mantz
University of Chicago
Career Start Year 1997
Number of shared co-authors 7
Jonathan D Tward
Huntsman Cancer Institute, University of Utah
Career Start Year 1994
Number of shared co-authors 6

Collaborators

Michael L Steinberg
University of California los angeles
Co-authored papers 12
Mitchell Kamrava
Cedars Sinai Medical Center
Co-authored papers 9
David Jeffrey Demanes
University of California los angeles
Co-authored papers 8
Patrick A Kupelian
university of california los angeles Medical Center
Co-authored papers 8
Christopher R King
University of California los angeles
Co-authored papers 5
Amar U Kishan
University of California los angeles
Co-authored papers 4
Cati Brown-Johnson
Stanford University School of Medicine
Co-authored papers 3
Steven M Asch
Center for Innovation to Implementation (Ci2i)
Co-authored papers 3
Aaron A Laviana
Dell Medical School, The University of Texas at Austin
Co-authored papers 2
Annette Ilg
Beth Israel Deaconess Medical Center and Harvard Medical School
Co-authored papers 2
Christopher S Saigal
university of california los angeles Center for Health Sciences
Co-authored papers 2
Stacie Vilendrer
Stanford University School of Medicine
Co-authored papers 2
Maie A St John
Co-authored papers 2
Minsong Cao
University of California Los Angeles
Co-authored papers 2
Douglas Niedzwiecki
University of California Los Angeles Health System
Co-authored papers 2
Michael A Burke
University of California Los Angeles Health System
Co-authored papers 2
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Co-authored papers 1
Aaron Lisberg
Jonsson Comprehensive Cancer Center, university of california los angeles
Co-authored papers 1
Kiri A Sandler
Oregon Health and Science University
Co-authored papers 1
Edward B Garon
David Geffen School of Medicine, University of California Los Angeles
Co-authored papers 1
Nicholas G Nickols
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Co-authored papers 1
Daniel J Margolis
Weill Cornell Medical College
Co-authored papers 1
William Hsu
Co-authored papers 1
Hung-Jui Tan
University of North Carolina
Co-authored papers 1
Alan L Kaplan
Houston Methodist Hospital
Co-authored papers 1
Chandan Kundavaram
USC Institute of Urology, Keck School of Medicine, University of Southern California
Co-authored papers 1
Andrew K Moriarity
Michigan State University, College of Human Medicine
Co-authored papers 1
Silvia C Formenti
Weill Cornell Medical College
Co-authored papers 1
Steven S Raman
University of California, Los Angeles David Geffen School of Medicine
Co-authored papers 1
Jim C Hu
Weill Cornell Medical Center
Co-authored papers 1
Release 1.2